Whether individual classes of antihypertensives have specific benefits for prevention of cardiovascular disease, over and above blood pressure reduction, has been the subject of long and often heated debate. Meta-analyses of many studies, involving thousands of patients, suggest minimal or no additional benefit from specific antihypertensive regimens.1,2 However, this view has been challenged r...
